Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP109544.RArsBPHfK7rIgDj4DmPGzJTvebIhy_lIa9ZpwZaRdT4f0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP109544.RArsBPHfK7rIgDj4DmPGzJTvebIhy_lIa9ZpwZaRdT4f0130_assertion type Assertion NP109544.RArsBPHfK7rIgDj4DmPGzJTvebIhy_lIa9ZpwZaRdT4f0130_head.
- NP109544.RArsBPHfK7rIgDj4DmPGzJTvebIhy_lIa9ZpwZaRdT4f0130_assertion description "[Estimation of CT7, also referred to as MAGE-C1, immunoreactivity is of limited prognostic usefulness in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109544.RArsBPHfK7rIgDj4DmPGzJTvebIhy_lIa9ZpwZaRdT4f0130_provenance.
- NP109544.RArsBPHfK7rIgDj4DmPGzJTvebIhy_lIa9ZpwZaRdT4f0130_assertion evidence source_evidence_literature NP109544.RArsBPHfK7rIgDj4DmPGzJTvebIhy_lIa9ZpwZaRdT4f0130_provenance.
- NP109544.RArsBPHfK7rIgDj4DmPGzJTvebIhy_lIa9ZpwZaRdT4f0130_assertion SIO_000772 17607369 NP109544.RArsBPHfK7rIgDj4DmPGzJTvebIhy_lIa9ZpwZaRdT4f0130_provenance.
- NP109544.RArsBPHfK7rIgDj4DmPGzJTvebIhy_lIa9ZpwZaRdT4f0130_assertion wasDerivedFrom lhgdn-20090331 NP109544.RArsBPHfK7rIgDj4DmPGzJTvebIhy_lIa9ZpwZaRdT4f0130_provenance.
- NP109544.RArsBPHfK7rIgDj4DmPGzJTvebIhy_lIa9ZpwZaRdT4f0130_assertion wasGeneratedBy ECO_0000203 NP109544.RArsBPHfK7rIgDj4DmPGzJTvebIhy_lIa9ZpwZaRdT4f0130_provenance.